Emerging research from the UK is generating significant buzz surrounding a possible combination between high-dose Nicotinamide Adenine Dinucleotide supplementation – specifically doses of 1000mg – and the novel drug Retatrutide. Early findings suggest that this unique strategy may offer a conside